Showing results (741-750 of 3,020) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|January 18, 2011
Pompe disease: from new views on pathophysiology to innovative therapeutic strategiesGiancarlo Parenti, Generoso AndriaCurrent Pharmaceutical Biotechnology|January 18, 2011
Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidosesDao PanCurrent Pharmaceutical Biotechnology|January 18, 2011
Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategiesJ de Ruijter, M J Valstar, F A WijburgCurrent Pharmaceutical Biotechnology|January 18, 2011
The vasoactive role of nitric oxide: physiological and morphological aspectsSona CacanyiovaCurrent Pharmaceutical Biotechnology|January 18, 2011
Role of endothelial nitric oxide in cerebrovascular regulationDmitriy N Atochin, Paul L HuangCurrent Pharmaceutical Biotechnology|December 31, 2010
Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterolThomas Pfeifer, Marlene Buchebner, Prakash G Chandak, et al.Current Pharmaceutical Biotechnology|October 14, 2010
Novel vitreous modulators for pharmacologic vitreolysis in the treatment of diabetic retinopathyElaine de Paula Fiod Costa, Eduardo B Rodrigues, Michel E Farah, et al.Current Pharmaceutical Biotechnology|October 14, 2010
Protein kinase C inhibitors in the treatment of diabetic retinopathy. ReviewM I López GálvezCurrent Pharmaceutical Biotechnology|October 14, 2010
Diabetic retinopathy, superoxide damage and antioxidantsJulia M Santos, Ghulam Mohammad, Qing Zhong, et al.Current Pharmaceutical Biotechnology|October 12, 2010
TRPV1 and synaptic transmissionJose A Matta, Gerard P AhernPageof 302